Cargando…
Therapy Targets SARS-CoV-2 Infection-Induced Cell Death
Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2 has become a global health issue. The clinical presentation of COVID-19 is highly variable, ranging from asymptomatic and mild disease to severe. However, the mechanisms for the high mortality induced by SARS-CoV-2 infection are still not well...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152132/ https://www.ncbi.nlm.nih.gov/pubmed/35655782 http://dx.doi.org/10.3389/fimmu.2022.870216 |
_version_ | 1784717577543483392 |
---|---|
author | Zhu, Zhoujie Shi, Jiayi Li, Long Wang, Jinling Zhao, Yufen Ma, Huabin |
author_facet | Zhu, Zhoujie Shi, Jiayi Li, Long Wang, Jinling Zhao, Yufen Ma, Huabin |
author_sort | Zhu, Zhoujie |
collection | PubMed |
description | Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2 has become a global health issue. The clinical presentation of COVID-19 is highly variable, ranging from asymptomatic and mild disease to severe. However, the mechanisms for the high mortality induced by SARS-CoV-2 infection are still not well understood. Recent studies have indicated that the cytokine storm might play an essential role in the disease progression in patients with COVID-19, which is characterized by the uncontrolled release of cytokines and chemokines leading to acute respiratory distress syndrome (ARDS), multi-organ failure, and even death. Cell death, especially, inflammatory cell death, might be the initiation of a cytokine storm caused by SARS-CoV-2 infection. This review summarizes the forms of cell death caused by SARS-CoV-2 in vivo or in vitro and elaborates on the dedication of apoptosis, necroptosis, NETosis, pyroptosis of syncytia, and even SARS-CoV-2 E proteins forming channel induced cell death, providing insights into targets on the cell death pathway for the treatment of COVID-19. |
format | Online Article Text |
id | pubmed-9152132 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91521322022-06-01 Therapy Targets SARS-CoV-2 Infection-Induced Cell Death Zhu, Zhoujie Shi, Jiayi Li, Long Wang, Jinling Zhao, Yufen Ma, Huabin Front Immunol Immunology Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2 has become a global health issue. The clinical presentation of COVID-19 is highly variable, ranging from asymptomatic and mild disease to severe. However, the mechanisms for the high mortality induced by SARS-CoV-2 infection are still not well understood. Recent studies have indicated that the cytokine storm might play an essential role in the disease progression in patients with COVID-19, which is characterized by the uncontrolled release of cytokines and chemokines leading to acute respiratory distress syndrome (ARDS), multi-organ failure, and even death. Cell death, especially, inflammatory cell death, might be the initiation of a cytokine storm caused by SARS-CoV-2 infection. This review summarizes the forms of cell death caused by SARS-CoV-2 in vivo or in vitro and elaborates on the dedication of apoptosis, necroptosis, NETosis, pyroptosis of syncytia, and even SARS-CoV-2 E proteins forming channel induced cell death, providing insights into targets on the cell death pathway for the treatment of COVID-19. Frontiers Media S.A. 2022-05-17 /pmc/articles/PMC9152132/ /pubmed/35655782 http://dx.doi.org/10.3389/fimmu.2022.870216 Text en Copyright © 2022 Zhu, Shi, Li, Wang, Zhao and Ma https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Zhu, Zhoujie Shi, Jiayi Li, Long Wang, Jinling Zhao, Yufen Ma, Huabin Therapy Targets SARS-CoV-2 Infection-Induced Cell Death |
title | Therapy Targets SARS-CoV-2 Infection-Induced Cell Death |
title_full | Therapy Targets SARS-CoV-2 Infection-Induced Cell Death |
title_fullStr | Therapy Targets SARS-CoV-2 Infection-Induced Cell Death |
title_full_unstemmed | Therapy Targets SARS-CoV-2 Infection-Induced Cell Death |
title_short | Therapy Targets SARS-CoV-2 Infection-Induced Cell Death |
title_sort | therapy targets sars-cov-2 infection-induced cell death |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152132/ https://www.ncbi.nlm.nih.gov/pubmed/35655782 http://dx.doi.org/10.3389/fimmu.2022.870216 |
work_keys_str_mv | AT zhuzhoujie therapytargetssarscov2infectioninducedcelldeath AT shijiayi therapytargetssarscov2infectioninducedcelldeath AT lilong therapytargetssarscov2infectioninducedcelldeath AT wangjinling therapytargetssarscov2infectioninducedcelldeath AT zhaoyufen therapytargetssarscov2infectioninducedcelldeath AT mahuabin therapytargetssarscov2infectioninducedcelldeath |